Company Update: Eli Lilly & Company (NYSE:LLY) – Lilly’s Trulicity™ (dulaglutide) Now Available in U.S. Pharmacies

[PR Newswire] – INDIANAPOLIS, Nov. 10, 2014 /PRNewswire/ — The newest GLP-1 receptor agonist treatment option to help improve glycemic control type 2 diabetes in adults is now available in U.S. pharmacies. Eli . . . → Read More: Company Update: Eli Lilly & Company (NYSE:LLY) – Lilly’s Trulicity™ (dulaglutide) Now Available in U.S. Pharmacies Similar Articles: Company Update (NYSE:LLY): Lilly Declares Fourth-Quarter 2014 Dividend Market Update (NYSE:LLY): New type 2 diabetes treatment Jardiance® (empagliflozin) tablets for adults now available in U.S. pharmacies Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly to Participate in Morgan Stanley 2014 Global Healthcare Conference